The Bob Harrington Show
View all posts »#51: Stem-cell therapy in cardiovascular medicine: An update with Dr Bobby Robbins
Sep 10, 2012 16:15 EDT-
2Comments
-
Read later
Regenerative therapy using stem cells has—for a long time—shown great potential to impact cardiovascular medicine. What's the current state of the field? Dr Bobby Robbins shares his thoughts about current and future research including his goal to use embryonic stem cells in the human heart within 5 years.
See also:
- Stem-cell findings strike at long-held vascular disease dogma
- Stem-cell therapy still needs a lot more study
Dr Robbins has served on the corporate physician advisory group for Medtronic. He sits on the board of directors of Cytograft Tissue Engineering and Co-Repair, and is an advisor to PEAK Surgical.
For Dr Harrington's disclosures, click here.
Your comments
 |
 |
 |
||
 |
|
 |
||
 |
 |
 |
||
 |
|
|
 |
|
 |
 |
 |
||
 |
|
|
 |
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
||||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
